advertisement
Walt J 2
Showing records 1 to 2 | Display all abstracts from Walt J13582 Estimated comparative costs of achieving a 20% reduction in intraocular pressure with bimatoprost or latanoprost in patients with glaucoma or ocular hypertension
Fiscella R; Walt J
Drugs and Aging 2006; 23: 39-47
13720 Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications
Goldberg LD; Walt J
PharmacoEconomics 2006; 24: 251-264
